It's the money that counts
Pharmaceutical Technology Europe
Brussels report
As the introduction of new member states to the European Union edges closer, the debate in Brussels regarding healthcare for the enlarged Union becomes more heated. Health standards in new member states are predicted to increase, but the main worry for the usual protagonists is how will the European pharmaceutical industry fare?
This article is currently available in printed form only.
To ensure access to all articles from every issue of Pharmaceutical Technology Europesubscribe here now.
Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications
December 10th 2024This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
